- Home
- ACRV vs MIO Comparison
ACRV vs MIO Comparison
Compare ACRV & MIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- MIO
- Stock Information
- Founded
- ACRV 2018
- MIO 2021
- Country
- ACRV United States
- MIO United States
- Employees
- ACRV N/A
- MIO N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- MIO Investment Managers
- Sector
- ACRV Health Care
- MIO Finance
- Exchange
- ACRV Nasdaq
- MIO Nasdaq
- Market Cap
- ACRV 247.8M
- MIO 209.0M
- IPO Year
- ACRV 2022
- MIO N/A
- Fundamental
- Price
- ACRV $8.04
- MIO $12.23
- Analyst Decision
- ACRV Strong Buy
- MIO
- Analyst Count
- ACRV 5
- MIO 0
- Target Price
- ACRV $22.40
- MIO N/A
- AVG Volume (30 Days)
- ACRV 44.7K
- MIO 46.0K
- Earning Date
- ACRV 11-13-2024
- MIO 01-01-0001
- Dividend Yield
- ACRV N/A
- MIO 4.57%
- EPS Growth
- ACRV N/A
- MIO N/A
- EPS
- ACRV N/A
- MIO N/A
- Revenue
- ACRV N/A
- MIO N/A
- Revenue This Year
- ACRV N/A
- MIO N/A
- Revenue Next Year
- ACRV N/A
- MIO N/A
- P/E Ratio
- ACRV N/A
- MIO N/A
- Revenue Growth
- ACRV N/A
- MIO N/A
- 52 Week Low
- ACRV $3.19
- MIO $9.18
- 52 Week High
- ACRV $11.90
- MIO $11.36
- Technical
- Relative Strength Index (RSI)
- ACRV 48.60
- MIO 50.75
- Support Level
- ACRV $7.69
- MIO $11.82
- Resistance Level
- ACRV $8.54
- MIO $12.23
- Average True Range (ATR)
- ACRV 0.34
- MIO 0.09
- MACD
- ACRV -0.03
- MIO 0.02
- Stochastic Oscillator
- ACRV 23.59
- MIO 81.46
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About MIO Pioneer Municipal High Income Opportunities Fund Inc.
Pioneer Municipal High Income Opportunities Fund Inc. is a diversified, closed-end management investment company. The Fund's primary investment objective is to provide holders of the Fund's common stock with a high level of current income exempt from regular federal income tax.